Sunday 7th December

Poster session

N.2. e-Poster

C.4. Challenging the status quo in CKD and AKI

1. SGLT2 inhibitors: update
2. The place of GLP-1 agonists in clinical practice

3. The place of MRA in clinical practice

4. Novel biomarkers in AKI

C.5. Κλινική Νεφρολογία

1. Νέες και αναδυόμενες θεραπείες στη νεφροπάθεια IgA M. Στάγκου

2. Πώς πρέπει να αντιμετωπίζω τον ασθενή με νεφροπάθεια IgA; J. Levy

3. Νεότεροι βιοδείκτες στην ΟΝΑ N. Μαλλιαράκη

N.4. Hypertension

1. Guidelines on hypertension in CKD patients

2. Novel and emerging treatments in hypertension

N.5. Cardiovascular morbidity in CKD

1. Treatment on hyperlipidaemia: what's new?

2. Challenges in the management of hyperkalaemia

N.6. Polycystic kidney disease

1. The importance of the total kidney volume (TKV) - new data and applications

2. New KDIGO Guidelines

3. Genetic tests: what should I know?

N.7. Fabry Disease

1. Fabry Disease: what should I know?

N.8. Haemodialysis

1. Uremic pruritus: systematic review, evaluation and treatment

2. HIF inhibitors: their place in clinical practice

3. Management of bone mineral disease: what is the target and how to achieve it